Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.2B | 6.2B | 5.8B | 6.1B |
Cost of revenue | 5.1B | 4.2B | 3.8B | 4.0B |
Gross profit | 2.2B | 2.0B | 2.0B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 409M | 325M | 421M | 472M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 328M | 204M | 355M | 399M |
Tax provision | 67M | 29M | 70M | 85M |
Net income | 261M | 175M | 285M | 314M |
Basic EPS | 2.3 | 1.7 | 2.7 | 3.0 |
Diluted EPS | 2.3 | 1.7 | 2.7 | 2.9 |
Basic average shares | 106.3M | 106.3M | 106.3M | 106.3M |
Diluted average shares | 106.5M | 106.4M | 106.5M | 106.6M |
EBITDA | 635M | 622M | 632M | 683M |
Net income from continuing op. | 409M | 276M | 420M | 471M |
Minority interests | -12M | 3M | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |